New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.
New Delhi [India], January 23 (ANI): The Centre on Sunday said that it has provided over 161.47 crore COVID-19 vaccine doses provided to States and Union Territories (UTs) so far.
New Delhi [India], January 22 (ANI): More than 12.79 crore balance and unutilized COVID-19 vaccine doses are still available with States and Union Territories, the Ministry of Health and Family Welfare informed on Saturday.
New Delhi [India], January 21 (ANI): In the recent update on the CoWIN portal to receive the COVID-19 vaccine, the Union Ministry of Health and Family Welfare on Friday said that up to six members can now register using a single mobile number.
New Delhi [India], January 21 (ANI): The Central Government on Friday said that over 12.73 crore balance and unutilized COVID-19 vaccines are still available with the States and Union Territories to be administered.
New Delhi [India], January 20 (ANI): Russia's COVID-19 vaccine Sputnik V has demonstrated strong protection against the Omicron variant of the virus compared to the Pfizer vaccine, according to a study conducted at the Spallanzani Institute in Italy in collaboration with investors in the Spu
New Delhi [India], January 20 (ANI): The Central government on Thursday informed that 72 per cent of India's adult population is fully vaccinated whereas around 52 per cent of children in the 15-18 years old age group have been inoculated with the first dose of COVID-19 vaccine.
New Delhi [India], January 20 (ANI): With the administration of over 73 lakh COVID-19 vaccine doses in the last 24 hours, India's cumulative vaccination coverage has exceeded 159.67 crore, said Ministry of Health and Family Welfare on Thursday.
New Delhi [India], January 20 (ANI): The Centre on Thursday said that more than 12.72 crore balance and unutilized COVID-19 vaccine doses are still available with the States and Union Territories to be administered.
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po